Stay updated on Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial page.

Latest updates to the Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial page
- Check5 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2. These are administrative site changes and do not modify study data or content.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe new version shows Revision: v3.3.2 replacing v3.3.1, a minor site revision that does not alter the study history items. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedThe version history shows an added revision v3.3.1 and removal of v3.2.0, reflecting a minor maintenance update to the page history.SummaryDifference0.1%

- Check41 days agoChange DetectedThe government funding/status notice on the page has been removed. It previously warned about potential updates and delays in site operations.SummaryDifference0.8%

- Check55 days agoChange DetectedVersion history shows updates to recruitment status and changes to core study details (arms/interventions, outcome measures, and contacts/locations).SummaryDifference0.1%

- Check84 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

Stay in the know with updates to Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial page.